Diagnostic work-up and advancement in the diagnosis of gastroenteropancreatic neuroendocrine neoplasms

A Koffas, A Giakoustidis, A Papaefthymiou… - Frontiers in …, 2023 - frontiersin.org
Neuroendocrine neoplasms (NENs) are a heterogeneous group of neoplasms ranging from
well-differentiated, slowly growing tumors to poorly differentiated carcinomas. These tumors …

What do we know about carcinoid heart disease in the present era?

M Pęczkowska… - Polish Heart …, 2022 - journals.viamedica.pl
Carcinoid heart disease (CHD) is a severe complication of carcinoid syndrome (CS) found
primarily in patients with small intestine neuroendocrine neoplasms (SI-NENs). Patients who …

Efficacy, safety and unmet needs of evolving medical treatments for carcinoid syndrome

A Koumarianou, K Daskalakis, M Tsoli… - Journal of …, 2022 - Wiley Online Library
This review reports on the currently available medical treatment options for the control of
symptoms due to carcinoid syndrome in patients with neuroendocrine tumors. The efficacy …

Current practice in carcinoid heart disease and burgeoning opportunities

C Lenneman, D Harrison, SL Davis… - Current Treatment Options …, 2022 - Springer
Opinion statement Cardiac surgery with tricuspid valve and potentially pulmonic valve
replacement at an experienced center is currently the most effective strategy available for …

[HTML][HTML] Competing risk analysis of cardiovascular-specific mortality in typical carcinoid neoplasms of the lung: A SEER database analysis

H Xing, C Wu, D Zhang, X Zhang - Medicine, 2023 - journals.lww.com
Cardiovascular mortality (CVM) is a growing concern for cancer survivors. This study aimed
to investigate the mortality patterns of individuals with typical carcinoid (TC) tumors, identify …

[HTML][HTML] Screening for carcinoid heart disease: Trends and future Perspectives

B Mouser, JR Howe, O Atari, JS Dillon… - International Journal of …, 2024 - Elsevier
Background Screening for carcinoid heart disease (CHD), has historically lacked consensus
expert guidelines. In 2017, the North American Neuroendocrine Tumor Society (NANETS) …

Carcinoid heart disease: a potentially fatal complication of carcinoid syndrome

M Bdiwi, K Ramaseshan, M Uddin, M Goel… - … Case Reports CP, 2023 - casereports.bmj.com
Carcinoid heart disease is a unique and serious cardiac complication of the neuroendocrine
tumour that affects the right side of the heart, especially the tricuspid and pulmonic valves …

Rediscovering biomarkers in for the diagnosis and early treatment response in NEN. Reborn Study

G Puliani - 2023 - iris.uniroma1.it
Abstract Introduction: Neuroendocrine neoplasms (NENs) are heterogeneous in terms of
primary site, behavior, and response to treatment. The possibility to rely on diagnostic and …

[PDF][PDF] Carcinoid Heart Disease–A 2022 Retrospective

CE Nistor, M Carsote, AE Ranetti… - Romanian Journal of - revistamedicinamilitara.ro
We aim to introduce a 2022 update on CHD (carcinoid heart disease) considering a
multidisciplinary perspective. This is a narrative mini-review. We searched English, full …

[PDF][PDF] Revista Portuguesa de Endocrinologia, Diabetes e Metabolismo

CA Kocha - Rev Port Endocrinol Diabetes Metab, 2012 - en.spedmjournal.com
Obesity is a global health problem, most of which can probably be improved by changing
dietary habits, with less consumption of processed and preserved foods and by increasing …